Recent Articles from StockStory

Shares of beauty products company Estée Lauder (NYSE:EL) jumped 5.4% in the morning session after Deutsche Bank analysts upgraded the stock from Hold to Buy and raised the price target from $71 to $95 (implying more than a 20% upside), noting that demand concerns in the beauty space were fading.

Shares of server solutions provider Super Micro (NASDAQ:SMCI) fell 5.8% in the morning session after the company announced a proposed offering of $2.0 billion in convertible senior notes due 2030. The stock was likely down due to concerns about the dilutive effect of the notes, which can be converted to the company's ordinary stock, raising the total share count.

Shares of electric vehicle pioneer Tesla (NASDAQ:TSLA) jumped 7.6% in the morning session after the company launched its highly anticipated robotaxi service in Austin, Texas, impressing Wall Street. 

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 29.2% in the morning session after Novo Nordisk, the maker of the weight loss drug Wegovy, announced it would terminate its agreement with the company (Hims & Hers). 

Texas-based bank holding company Veritex Holdings (NASDAQGM:VBTX) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 4.2% year on year to $110.2 million. Its non-GAAP profit of $0.54 per share was 5.2% above analysts’ consensus estimates.

Regional banking company Webster Financial (NYSE:WBS) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 5.7% year on year to $704.8 million. Its non-GAAP profit of $1.30 per share was 5.8% below analysts’ consensus estimates.

Regional banking company WesBanco (NASDAQ:WSBC) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 33.6% year on year to $193.2 million. Its non-GAAP profit of $0.66 per share was 16% above analysts’ consensus estimates.

Regional banking company Wintrust Financial (NASDAQ:WTFC) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 6.3% year on year to $643.1 million. Its non-GAAP profit of $2.69 per share was 8.1% above analysts’ consensus estimates.

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.

Even if they go mostly unnoticed, industrial businesses are the backbone of our country. But they are at the whim of volatile macroeconomic factors that influence capital spending (like interest rates), and the market seems convinced that demand will slow. Due to this bearish outlook, the industry has tumbled by 2.3% over the past six months. This drawdown was disheartening since the S&P 500 held its ground.

A company with profits isn’t always a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Even if they go mostly unnoticed, industrial businesses are the backbone of our country. Still, their generally high capital requirements expose them to the ups and downs of economic cycles, and the market seems to be baking in a prolonged downturn as the industry has shed 2.3% over the past six months. This drop was disappointing since the S&P 500 stood firm.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Banks serve as the backbone of the economy, facilitating lending, deposits, and financial services that keep businesses and consumers moving forward. But concerns about loan losses and tightening regulations have tempered enthusiasm, and over the past six months, the banking industry has pulled back by 6.9%. This drop was disappointing since the S&P 500 stood firm.

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Banks play a critical role in the financial system, providing everything from commercial loans to wealth management and payment processing services. But concerns about loan losses and tightening regulations have tempered enthusiasm, and over the past six months, the banking industry has pulled back by 6.9%. This drop was discouraging since the S&P 500 held its ground.

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling knives.

Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

A company with profits isn’t always a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

Banks use their capital and expertise to help businesses grow while offering consumers essential financial products like mortgages and credit cards. Still, investors are uneasy as banks face challenges from credit quality concerns and potential regulatory changes. These doubts have caused the industry to lag recently as banking stocks have collectively shed 6.9% over the past six months. This drawdown was disheartening since the S&P 500 held steady.

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?

Restaurants increase convenience and give many people a place to unwind. Still, their demand can ebb and flow with the broader economy because consumers can always cook meals at home when times are tough, and the market seems to be baking in a downturn for the industry - over the past six months, it has pulled back by 1.4%. This performance mirrored the S&P 500’s.

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor confidence when the ride gets bumpy.

Consumer internet businesses are redefining how people engage with the world by giving them instant connectivity and convenience. Luckily for them, the market seems to believe there is a long runway for growth as the industry has recorded a 3.7% gain over the past six months while the S&P 500 was stuck in neutral.

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.

The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing. However, certain stocks in the index face challenges like profitability concerns, rising costs, or shifts in market trends.

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.

Incyte’s first quarter was marked by significant commercial momentum and robust top-line growth, leading to a positive market reaction. Management attributed the results to strong demand for Jakafi and Opselura, the initial sales contribution from recently launched Niktimvo, and continued expansion in dermatology and hematology-oncology portfolios. CEO Herve Hoppenot emphasized that “Q1 2025 puts us on a great trajectory for long-term growth with the continuous expansion of Apteloa, successful launch of NixTimo, and the successes of the pivotal studies in HS and proof of concept study in CSU.”

Kraft Heinz's first quarter results for 2025 were shaped by ongoing volume declines and increased investment in its brands amid a shifting consumer landscape. Management pointed to decreased sales volumes and softer demand in key categories as primary headwinds, but also highlighted continued efforts to renovate products and increase marketing spend. CEO Carlos Abrams-Rivera noted that, while improvements in brand quality and product innovation are underway, they are not yet evident in the financial results. He emphasized, "our commitment to making the necessary investments to deliver quality and value offerings to our consumers is unwavering."

Altria’s first quarter results were shaped by continued declines in its core cigarette volumes, which management attributed mainly to consumer migration toward illicit flavored e-vapor products and ongoing inflationary pressure. CEO Billy Gifford noted, “The cumulative impact of inflation over time is driving consumers to seek price relief, particularly through illicit e-vapor options.” Despite these headwinds, Altria leveraged robust pricing strategies and maintained profitability in its smokeable segment, supported by Marlboro’s brand strength and targeted use of promotional resources.

Cushman & Wakefield’s first quarter results were well received by the market, as management pointed to broad-based growth across each of its service lines. CEO Michelle MacKay highlighted that the firm’s focus on operational streamlining and disciplined investment over the past 18 months has begun to yield tangible benefits. She described the quarter as a turning point, noting, “We increased revenue in each of our service lines, achieving mid single-digit organic growth in our services business, two quarters ahead of target.”

Option Care Health’s first quarter results for 2025 delivered revenue and adjusted profits above Wall Street expectations, but the market responded cautiously. Management pointed to balanced growth across its acute and chronic therapy portfolios as key drivers, with acute therapies benefiting from improved intravenous bag supply and robust local execution. CEO John Rademacher highlighted the company’s ability to partner with referral sources and health plans, emphasizing, “our national scale and local responsiveness places us in a unique position.” The quarter also saw investments in technology and expanded nursing capabilities, while a muted impact from procurement changes in the STELARA therapy helped limit gross profit headwinds.

Coca-Cola’s first quarter results for 2025 reflected steady execution despite a changing consumer landscape and regional variability. Management highlighted that volume growth was driven by strength in Asia-Pacific and resilient performance in Latin America, while North America faced headwinds including softer consumer sentiment and temporary disruptions linked to misinformation about core products. CEO James Quincey emphasized, “Our system has quickly pivoted to prioritize the most impactful investment opportunities and is emphasizing faster decision making and greater agility to accelerate volume growth.”

A. O. Smith’s first quarter was marked by a positive market reaction, as the company exceeded Wall Street’s revenue and non-GAAP earnings expectations despite a modest year-over-year decline in sales. Management pointed to a challenging comparison with unusually high water heater volumes last year, combined with a more normalized demand environment in North America and continued economic softness in China. CEO Kevin Wheeler emphasized that the bulk of the quarter’s performance was driven by disciplined cost management, sequential volume improvement, and ongoing strength in high-efficiency boiler sales. Wheeler noted, “We are pleased with our sequential quarter-over-quarter improvement,” and highlighted that North American boiler sales outperformed, offsetting softer water heater volumes.

Xylem’s first quarter saw positive momentum, with management attributing the results to resilient demand across its water infrastructure and applied water segments. CEO Matthew Pine noted that revenue growth was supported by productivity improvements, disciplined operational execution, and early benefits from organizational simplification. The company’s backlog remained strong, and Pine highlighted Xylem’s ability to navigate industry challenges, stating, “We’re better positioned than most to address the water needs of communities and businesses because the portfolio we built is differentiated in every part of the water cycle.”

Pfizer’s first quarter results drew a positive market response as management emphasized margin improvement and disciplined expense control, even as revenue declined. CEO Albert Bourla credited robust execution in key therapeutic areas, particularly oncology and internal medicine, for helping offset lower sales from COVID-related products. CFO Dave Denton highlighted the impact of productivity programs and a refined commercial approach, noting that adjusted operating expenses fell meaningfully due to ongoing cost realignment. Management acknowledged external pressures, including U.S. policy changes and lower COVID demand, but pointed to operational efficiency as a key factor supporting profitability.

Labcorp’s first quarter saw steady execution in a complex environment, with results that prompted a positive market response. Management pointed to volume recovery in its Diagnostics Laboratories segment, following early quarter weather disruptions, and highlighted momentum from recent acquisitions such as Invitae. CEO Adam Schechter credited “strong managed care access and our payer contracts” for supporting growth, while noting that operational efficiencies helped offset inflation in personnel costs. The biopharma laboratory services segment also contributed, with improved margins and a robust book-to-bill ratio.

Over the past six months, BWX has been a great trade. While the S&P 500 was flat, the stock price has climbed by 27.8% to $143 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

Over the past six months, PACCAR’s stock price fell to $92.01. Shareholders have lost 12.1% of their capital, disappointing when considering the S&P 500 was flat. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

Over the past six months, Merit Medical Systems’s shares (currently trading at $91) have posted a disappointing 6.8% loss while the S&P 500 was flat. This might have investors contemplating their next move.